share_log

HC Wainwright & Co. Reiterates Buy on Century Therapeutics, Maintains $13 Price Target

HC Wainwright & Co. Reiterates Buy on Century Therapeutics, Maintains $13 Price Target

HC Wainwright & Co.重申买入Century Therapeutics,维持13美元的目标价
Benzinga ·  2023/12/07 06:32

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Century Therapeutics (NASDAQ:IPSC) with a Buy and maintains $13 price target.

HC Wainwright & Co. 分析师米切尔·卡普尔重申世纪疗法(纳斯达克股票代码:IPSC)的买入并维持13美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发